John Hancock Strategic Series has released its latest NPORT-P filing, showcasing its financial standing as of August 31, 2026. The report indicates that the company holds total assets of approximately $1.64 billion, with net assets reported at about $1.63 billion. This filing is significant as it provides insights into the company's investment management strategies and financial health.
Founded in Massachusetts, John Hancock Strategic Series operates under the investment entity type. The company is known for its diverse range of investment funds, contributing to the overall landscape of investment management. The latest filing, dated October 29, 2026, is part of a series of recent submissions, including multiple NPORT-P forms filed on the same day.
The filing reveals that as of the reporting date, the company had total liabilities amounting to approximately $15.03 million. This positions the net assets at about $1.63 billion, indicating a robust financial framework for the firm. The report further discloses that there are no outstanding amounts owed to banks, controlled companies, or other affiliates, highlighting a stable financial environment.
Among the notable details in the filing, the report outlines monthly total returns for various classes of shares. For example, the Class A shares reported a return of -0.16% for the first month, while Class C shares showed a return of -0.22%. These figures are crucial for investors evaluating the fund's performance and potential returns.
The NPORT-P filing also details the company's derivative positions and borrower relationships. Notably, John Hancock Strategic Series has engaged with several major financial institutions, including Citigroup Global Markets Inc. and Morgan Stanley and Co. LLC, for various financial transactions. These relationships may enhance the company's investment strategies and overall market positioning.
As the investment management industry continues to evolve, filings like this one from John Hancock Strategic Series play a vital role in providing transparency and insights into financial health and operational strategies. Investors and analysts will be closely monitoring these updates to gauge the company's performance and the broader trends in the investment sector.
Looking ahead, it remains to be seen how John Hancock Strategic Series will leverage its current assets and relationships to adapt to market changes. The filing does not specify immediate next steps or future filings, but the ongoing management of its investment portfolio will be crucial for maintaining investor confidence and achieving long-term growth.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






